11:30 Interactive Presentation on Successful Grant Writing Ann Belien - CEO, Rejuvenate Biomed

The ICFSR brings together clinical, academics and industry leaders to present and discuss the latest research on frailty and sarcopenia.

The Longevity Leaders World Congress is the definitive global meeting with the mission of extending human health span, delivering healthy ageing and financial wellness in the context of longevity.

Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs.

During the conference, you will learn how to create an optimal environment to enable elderly people to benefit from value added medicines and the role of the various healthcare stakeholders in this process. You will learn more about regulatory and legal topics, market access, the future outlook in the digital space of value added medicines and much more

A series of international meetings, with support from the Nathan Shock Centers Coordinating Center, will aim to increase and enhance our understanding of geroscience concepts, and to encourage researchers around the globe to integrate these concepts into their research endeavors, in order to accelerate the development of both prevention and intervention strategies.

Honored to speak about the challenges of developing healthy aging drugs at the healthy aging symposium at Biomed, University of Hasselt.

Rejuvenate Biomed has been chosen by our selection committee to participate as a Next Wave Presenting Company at Bio€quity Europe. Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial and BD&L community to do business with independently selected Presenting Companies.

The ICFSR brings together clinical, academics and industry leaders to present and discuss the latest research on frailty and sarcopenia.

The aims of the Task Force are to put together a limited number of KOL from academy, agencies and industries to work together on the design of next positive trials on frailty and sarcopenia.

What types of local or European grants are available for life sciences start-ups? What do you do when it is too late for Venture Capital and too early for Private Equity? What is the best financing strategy when transitioning from a bio-incubator into your own facilities? Are you aware of the existing tax incentives to optimise your business plan? There are so many questions about the best funding & financing strategies from start-up to scale-up and beyond.

De Vlerick Healthcare Conference richt zich tot alle professionals die actief zijn in de sector van de gezondheidszorg en de levenswetenschappen, en iedereen die gewoon op de hoogte wil blijven van de belangrijkste trends in de sector.

Op 18 oktober 2018 is het opnieuw zover! Tijdens de derde editie van de Happy Aging Day zetten ze opnieuw innovaties in de gezondheidszorg in de spotlights. Laat je inspireren door boeiende (inter)nationale toppers en ontdek de nieuwste ontwikkelingen in de gezondheidszorg op de innovatiemarkt.

Innovation in Benelux event at JLABS @ BE.

The 18th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry.

The Mechanisms of Aging conference will explore the regulation and function of genes and processes that are now known or suspected to control cellular and/or organismic aging.

The 2018 C. elegans “Topics” Meeting, covering Aging, Metabolism, Pathogenesis, Stress, and Small RNAs, on the campus of the University of Wisconsin – Madison. Memorial Union will host the many plenary sessions, posters and social gatherings of the meeting.

The conference features an exciting programme providing vital insight into the global life sciences’ landscape, B2B Partnering, a trade fair with 100+ exhibitors and a scientific poster area.

Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe, an organisation of EBD Group and BioCentury, has already showcased more than 700 leading European companies to thousands of investment and pharma business development professionals.

The world’s aging population and problems with morbidity have been increasing rapidly. Decreases in immune function and increases in chronic inflammation with age are a major contributor to age-related diseases. This Keystone Symposia conference will provide a venue for researchers from around the world to discuss current findings and fundamental research to understand the mechanisms underlying declining immune function, increasing chronic inflammation, and possible interventions. The meeting will address essential aspects of aging/longevity research, with particular emphasis on the immune system and inflammation including effects of immunosenescence on cancer, autoimmunity, vaccine response and infectious disease. Longitudinal studies on aging and immunity, frailty and effects on mortality, quality of life and survival will also be covered as well as biomarkers of the aging immune system, mechanisms for generating chronic inflammation including the SASP, telomeres and the microbiome, regulation of aging and age-related immune function, and therapeutic approaches to slow aging and/or improve the immune system. The adaptive, innate and mucosal immune systems will be covered as these systems have a significant impact on human aging. Questions to be addressed include: 1) What changes in the immune system contribute to the observed decline in immune function and increase in the chronic inflammatory state? 2) How do diseases of aging or decreased immunity develop, and what can be done to prevent or reverse them? To address these questions, the symposium will gather investigators from interdisciplinary areas on aging, inflammation and immunology and will focus first on the human and secondly the murine immune systems.